申请人:E. I. Du Pont de Nemours and Company
公开号:US04624964A1
公开(公告)日:1986-11-25
Aryl oxo-alkynoates are 5-lipoxygenase inhibitors, making them useful for the treatment of inflammation, chronic obstructive lung disease or psoriasis. These compounds have the formula: ##STR1## wherein n is 1-12; R.sup.1 is C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, or phenyl; and Aryl is naphthyl, phenyl or phenyl substituted with a variety of groups.
芳基氧代炔酸酯是5-脂氧化酶抑制剂,因此它们对于治疗炎症、慢性阻塞性肺病或牛皮癣非常有用。这些化合物的化学式为:##STR1## 其中n为1-12;R.sup.1为C.sub.1 -C.sub.6烷基,C.sub.2 -C.sub.6烯基或苯基;芳基为萘基、苯基或苯基上取代有各种基团。